Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2003
03/25/2003US6537773 Open reading frames; gene expression; genetic vectors; computer based storage of sequence information; use detection and diagnosis of Mycoplasma
03/25/2003US6537766 Correlation with lymphoid cell abnormalities; use in the detection and treatment of lymphomas; cancer
03/25/2003US6537594 Vaccina virus comprising cytokine and/or tumor associated antigen genes
03/25/2003US6537555 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
03/25/2003US6537554 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
03/25/2003US6537551 Anti-tumor agent comprising salmosin as an active ingredient
03/25/2003US6537542 Homologous recombination
03/25/2003US6537541 Implantation of HSV-TK retrovirus producer cells to destroy glioma
03/25/2003US6537540 Administering recombinant adeno-associated virus vector; polynucleotide encoding fusion polypeptide with extracellular domain of the TNF receptor and a constant domain of an IgG1 molecule
03/25/2003US6537539 Immune cell cytokine
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/20/2003WO2003023066A1 Expression profiling in the intact human heart
03/20/2003WO2003023048A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l)
03/20/2003WO2003023026A1 Alphavirus replicon vector systems
03/20/2003WO2003023021A2 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
03/20/2003WO2003023015A2 Method for expression of small antiviral rna molecules within a cell
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003023001A2 Novel proteins and nucleic acids encoding same
03/20/2003WO2003023000A2 Linear dna fragments for gene expression
03/20/2003WO2003022998A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022988A2 Adipose-derived stem cells and lattices
03/20/2003WO2003022886A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003WO2003022882A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/20/2003WO2003022880A2 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003WO2003022874A1 Antagonist peptides to vegr receptor flt-1
03/20/2003WO2003022311A1 Adenoviral vector and related system and methods of making and use
03/20/2003WO2003022298A2 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003WO2003022228A2 Method for producing transgenic birds and fish
03/20/2003WO2003022224A2 Cox-2 function and wound healing
03/20/2003WO2003022212A2 Anti-tumor effects of prostate carcinoma tumor antigen-1
03/20/2003WO2003022202A2 Compositions and methods for treatment of cancer
03/20/2003WO2003022123A2 Methods of kidney transplantation utilizing developing nephric tissue
03/20/2003WO2003022052A1 Method for expression of small rna molecules within a cell
03/20/2003WO2003022040A2 Method for producing transgenic animals
03/20/2003WO2003000280A3 Abin-mediated hepatitis protection
03/20/2003WO2002099094A3 Human serine/threonine protein kinase-like enzyme
03/20/2003WO2002099075A3 Prmts as modifiers of the p53 pathway and methods of use
03/20/2003WO2002096364A3 Feline bronchioloalveolar lung carcinoma xenograft and cell line
03/20/2003WO2002094983A3 Dna-antibody complexes to enhance gene transfer
03/20/2003WO2002090545A9 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide
03/20/2003WO2002087509A3 Colloidal metal compositions and methods
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002077194A3 Polymer synthesis
03/20/2003WO2002069908A3 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
03/20/2003WO2002053760A3 Chimeric cytolytic viruses for cancer treatment
03/20/2003WO2002053733A3 Regulation of human b7-h2 protein
03/20/2003WO2002053728A3 Gene disruption methodologies for drug target discovery
03/20/2003WO2002053171A3 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity
03/20/2003WO2002042447A3 Surface transfection and expression procedure
03/20/2003WO2002038726A3 Paramyxovirus vector for gene transfer to the cardiovascular system
03/20/2003WO2002024897A9 Conditionally replicating viral vectors and their use
03/20/2003WO2002022809A9 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
03/20/2003WO2002020748A3 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof
03/20/2003WO2002020032A9 Stat3 agonists and antagonists and therapeutic uses thereof
03/20/2003WO2001078894A3 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
03/20/2003WO2001072341A3 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
03/20/2003US20030056241 Chicken leukemia inhibitory factor (LIF) and gene thereof
03/20/2003US20030056240 Transgenic animal model for use in the treatment of diabetes
03/20/2003US20030056231 Development of transgenic model for interventions in neurodegenerative diseases
03/20/2003US20030056229 Nucleotide sequences coding polypeptide for use in the treatment of leukemias, autoimmune and arthritic diseases
03/20/2003US20030055236 Secreted protein HKABT24
03/20/2003US20030055216 Nucleotide sequences coding polypeptide for use in the treatment of tumors
03/20/2003US20030055019 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
03/20/2003US20030055017 Gene therapy
03/20/2003US20030055015 Therapy and prophylaxis of diseases
03/20/2003US20030054994 Apoptosis inducing proteinaceous substance
03/20/2003US20030054993 For contraception in a mammal, for therapy of infertility
03/20/2003US20030054990 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
03/20/2003US20030054986 Novel DNA and to the recombinant production of novel polypeptides encoded by that DNA
03/20/2003US20030054525 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R / (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
03/20/2003US20030054514 Novel polynucleotides and proteins encoded thereby
03/20/2003US20030054498 Recombinant vector for use in gene therapy for insulin-dependent diabetes mellitus and therapeutic composition thereof
03/20/2003US20030054494 Novel chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
03/20/2003US20030054446 Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379
03/20/2003US20030054445 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01
03/20/2003US20030054421 Nucleotide sequences coding polypeptide for use in the treatment of cancer
03/20/2003US20030054420 Nucleic acids, proteins, and antibodies
03/20/2003US20030054409 Novel complex-forming proteins
03/20/2003US20030054405 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054392 Expression vector for use in the transfer of genetic information
03/20/2003US20030054380 Diagnosing long qt syndrome; obtain sample, extract nucleotide sequences, incubate with probe, detect polymorphism, presence of polymorphism indicates long qt syndrome
03/20/2003US20030054375 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of connective tissue and cancer disorders
03/20/2003US20030054365 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression
03/20/2003US20030054341 Viral nucleotide sequences for use in diagnosis, prevention and treatment of viral diseases
03/20/2003US20030054013 Tuberculosis therapy; anticancer agents
03/20/2003US20030053997 Expansion in situ; cognition activators
03/20/2003US20030053996 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/20/2003US20030053995 Methods and compositions for inhibiting EGF receptor activity
03/20/2003US20030053993 Regeneration of nerve cells
03/20/2003US20030053992 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/20/2003US20030053991 Retinoic acid receptor beta-2, its agonists, and gene theraphy vectors for the treatment of neurological disorders
03/20/2003US20030053990 Virus vectors and methods of making and administering the same
03/20/2003US20030053989 Administering nucleic acid
03/20/2003US20030053988 Genetic engineering; culture product; process control
03/20/2003US20030053987 Synthetic hepatitis c genes
03/20/2003US20030053978 Antitumor agents
03/20/2003CA2461692A1 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003CA2460509A1 Synthetic hcv envelope proteins and their use for vaccination
1 ... 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 ... 870